Oct 21, 2024 Posted on 21 October 20246 November 2024 Sanofi in ‘exclusive negotiations’ to sell 50% stake in €16B consumer health unit Opella
Oct 17, 2024 Posted on 17 October 202417 October 2024 Bayer applies for EU approval of menopause drug elinzanetant
Oct 07, 2024 Posted on 7 October 20247 October 2024 Oncolytics targets accelerated approval for oncolytic virus therapy
Oct 04, 2024 Posted on 4 October 20244 October 2024 US’ top IV fluid maker Baxter voices uncertainty about recovery timeline at North Carolina facility hit by Helene
Oct 01, 2024 Posted on 1 October 20244 October 2024 Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo
Sep 17, 2024 Posted on 17 September 20245 November 2024 Disc teases potential NDA for rare skin disorder drug
Sep 05, 2024 Posted on 5 September 20249 October 2024 The pathway to preventative health: How pharma can support the NHS Long Term Plan
Sep 03, 2024 Posted on 3 September 20244 October 2024 Novaliq and Laboratoires Théa announce EC approval for dry eye disease therapy
Sep 02, 2024 Posted on 2 September 20248 October 2024 EMA starts review into hair loss drugs about potential link to suicidal thoughts
Aug 28, 2024 Posted on 28 August 202430 October 2024 Orbia Wins ESG Champion Award from EHS Daily Advisor
